Acne Vulgaris-Solution

The recent scientific findings about the role of Propionibacterium acnes (P. acnes) in acne vulgaris, have opened the path for the development of a new, highly specific and efficacious acne therapy. Our therapeutic product is designed to support human immune system in controlling  P. acnes growth in the skin and prevent it from damaging the cellular lining of our skin pores. Our intention is to provide not just a more efficient treatment of acne, but also to prevent its formation and damage to skin surface in the form of scars. Therefore, both therapeutic and prophylactic immunotherapy may be possible.

ProVaDis: origimm biotechnology, vienna-